| Veröffentlichte Version Download ( PDF | 1MB) | Lizenz: Creative Commons Namensnennung 4.0 International |
Real-world analysis of brain atrophy in multiple sclerosis patients with an artificial intelligence based software tool
Reinhardt, Caroline
, Angstwurm, Klemens
, Freudenstein, David, Lee, De-Hyung, Wendl, Christina und Linker, Ralf A.
(2024)
Real-world analysis of brain atrophy in multiple sclerosis patients with an artificial intelligence based software tool.
Neurological Research and Practice 6 (1).
Veröffentlichungsdatum dieses Volltextes: 19 Aug 2024 08:59
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.58848
Zusammenfassung
Background Atrophy of white and grey matter volumes occurs early in the brains of people with multiple sclerosis (pwMS) and has great clinical relevance. In clinical trials, brain atrophy can be quantified by magnetic resonance imaging (MRI) with automated software tools. Methods In this study, we analyze volumes of various brain regions with the software “md brain” based on routine MRI scans ...
Background
Atrophy of white and grey matter volumes occurs early in the brains of people with multiple sclerosis (pwMS) and has great clinical relevance. In clinical trials, brain atrophy can be quantified by magnetic resonance imaging (MRI) with automated software tools.
Methods
In this study, we analyze volumes of various brain regions with the software “md brain” based on routine MRI scans of 53 pwMS in a real-world setting. We compare brain volumes of pwMS with an EDSS ≥ 3.5 and a disease duration ≥ 10 years to the brain volumes of pwMS with an EDSS < 3.5 and a disease duration < 10 years as well as with or without immunotherapy.
Results
pwMS with an EDSS ≥ 3.5 and a disease duration ≥ 10 years had significantly lower volumes of the total brain, the grey matter and of the frontal, temporal, parietal and occipital lobe regions as compared to pwMS with an EDSS < 3.5 and a disease duration < 10 years. Regional brain volumes were significantly lower in pwMS without immunotherapy.
Conclusions
The study showed that higher EDSS, longer disease duration and absence of immunotherapy was associated with lower volumes in a number of brain regions. Further real-world studies may include larger patient cohorts in longitudinal analyses.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Neurological Research and Practice | ||||
| Verlag: | Springer | ||||
|---|---|---|---|---|---|
| Band: | 6 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 1 | ||||
| Datum | 8 August 2024 | ||||
| Institutionen | Medizin > Lehrstuhl für Neurologie Medizin > Zentrum für Neuroradiologie | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | Multiple sclerosis, Brain atrophy, Magnetic resonance imaging, MR volumetry | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-588489 | ||||
| Dokumenten-ID | 58848 |
Downloadstatistik
Downloadstatistik